scholarly article | Q13442814 |
P50 | author | Anna Nicolaou | Q42293573 |
P2093 | author name string | Jenny Wang | |
David F Woodward | |||
Paula Urquhart | |||
P2860 | cites work | Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamily | Q24300569 |
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain | Q27655121 | ||
Horizons in therapy for corneal angiogenesis | Q27691454 | ||
N-acylation of phosphatidylethanolamine and its biological functions in mammals | Q28275595 | ||
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 | ||
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice | Q28296777 | ||
Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability | Q28480988 | ||
Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain | Q28732836 | ||
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation | Q30547823 | ||
Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis | Q33178917 | ||
Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells | Q34079507 | ||
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities | Q34094339 | ||
Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways | Q34328745 | ||
Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis | Q34662175 | ||
The N-acylethanolamine-hydrolyzing acid amidase (NAAA). | Q34666056 | ||
The endocannabinoid system is modulated in response to spinal cord injury in rats | Q34859495 | ||
UVB light regulates expression of antioxidants and inflammatory mediators in human corneal epithelial cells | Q35936908 | ||
Production and actions of the anandamide metabolite prostamide E2 in the renal medulla | Q36174214 | ||
Immune privilege and angiogenic privilege of the cornea | Q36722791 | ||
Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry. | Q36889907 | ||
Analysis of endocannabinoids, their congeners and COX-2 metabolites | Q36994900 | ||
Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo | Q37000921 | ||
Biological functions and metabolism of oleoylethanolamide | Q37243917 | ||
Lipidomic analysis of endocannabinoid metabolism in biological samples. | Q37295577 | ||
Production and physiological actions of anandamide in the vasculature of the rat kidney. | Q37372676 | ||
Dynamic regulation of barrier integrity of the corneal endothelium | Q37689474 | ||
Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just precursors of N-acylethanolamines (NAE). | Q37875929 | ||
Prostaglandin catabolic enzymes as tumor suppressors | Q37948688 | ||
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma | Q38018668 | ||
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. | Q38026790 | ||
Dynamic changes to the endocannabinoid system in models of chronic pain | Q38056398 | ||
Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB. | Q39831195 | ||
Multiple pathways involved in the biosynthesis of anandamide | Q40106992 | ||
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. | Q40385552 | ||
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism | Q40593008 | ||
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides | Q40702429 | ||
Prostaglandin D, E, and F synthases | Q41088110 | ||
Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. | Q41093128 | ||
Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris | Q41585257 | ||
Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry | Q42032224 | ||
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024). | Q42804690 | ||
Separation and quantification of sn-1 and sn-2 fatty acid positional isomers in phosphatidylcholine by RPLC-ESIMS/MS. | Q43251160 | ||
Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo | Q43669580 | ||
Topical cannabinoid agonist, WIN55,212-2, reduces cornea-evoked trigeminal brainstem activity in the rat. | Q44198290 | ||
Transforming growth factor-beta2 inhibition of corneal endothelial proliferation mediated by prostaglandin | Q44516554 | ||
Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry | Q44733045 | ||
Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS. | Q44816510 | ||
Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells | Q45225716 | ||
Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. | Q46423002 | ||
Finding of endocannabinoids in human eye tissues: implications for glaucoma | Q46432377 | ||
sn-position determination of phospholipid-linked fatty acids derived from erythrocytes by liquid chromatography electrospray ionization ion-trap mass spectrometry | Q46482522 | ||
Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2. | Q46693451 | ||
GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. | Q48227507 | ||
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation. | Q48486771 | ||
In vitro effects of anandamide and prostamide e2 on normal and transformed nerve cells. | Q48600669 | ||
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. | Q54599251 | ||
Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N-Docosahexaenoylethanolamine in Bovine Retina | Q60690628 | ||
Fatty acid and molecular species compositions of phospholipids and diacylglycerols from rat retinal membranes | Q70136076 | ||
Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits | Q70806485 | ||
N-Acylation of dog heart ethanolamine phospholipids by transacylase activity | Q71660413 | ||
NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs? | Q84289693 | ||
P433 | issue | 8 | |
P304 | page(s) | 1419-1433 | |
P577 | publication date | 2015-05-31 | |
P1433 | published in | Journal of Lipid Research | Q6295449 |
P1476 | title | Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea | |
P478 | volume | 56 |
Q90341465 | Aspects of Prostaglandin Glycerol Ester Biology |
Q28553623 | Modulation of Type-1 and Type-2 Cannabinoid Receptors by Saffron in a Rat Model of Retinal Neurodegeneration |
Q92912064 | Novel COX-2 products of n-3 polyunsaturated fatty acid-ethanolamine-conjugates identified in RAW264.7 macrophages |
Q37105737 | Quantitative analysis of N-acylphosphatidylethanolamine molecular species in rat brain using solid-phase extraction combined with reversed-phase chromatography and tandem mass spectrometry |
Search more.